THE IMPACT OF NOCTURIA ON MORTALITY : A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.53555/nnmhs.v9i4.1644Keywords:
Mortality, Nocturia, Sleed Disorder, VoidingAbstract
The International Classification of Sleep Disorders (ICS) describes nocturia as "voiding that occurs during the main sleep period". However, there are some medical specialists who do not believe that feeling one emptiness while sleeping qualifies as a clinically important occurrence. They believe that this viewpoint is supported by the evidence. This might be owing to the fact that some studies have indicated that having fewer than two voids every night is not an issue, whilst other studies have found that having more than two voids every night can reduce quality of life. Having fewer than two voids every night is not a problem. Having more than two voids every night is a problem. The most common and bothersome symptom related to urination is called nocturia. 10 million people in the United States suffer with nocturia, yet only 1.5 million get treated for it. This annoys seventy percent of individuals over the age of thirty who get up at least twice throughout the night to use the toilet. People who suffer from the illness known as nocturnal enuresis are characterized by their inability to recognize when they have a full bladder and their involuntary need to empty while sleeping. Nocturia is quite similar to nocturnal frequency, with the exception that sleep comes before and after episodes of urination. Even though voiding diaries call it nocturia, getting up in the middle of the night for any reason other than to urinate is not considered to be nocturia. Convenience void. Nocturia is frequently caused by overactive bladders rather than illnesses of the urinary system. Patients who experienced urine urgency in the afternoon were also likely to have nocturia. Mortality is increased in patients with nocturia who have three or more nocturnal voids per night. The condition known as nocturia has been linked to an increased risk of death. Those who have had nocturia more than three times are at an increased risk of mortality.
References
Herschorn S, Gajewski J, Schulz J, Corcos J. A population-based study of urinary symptoms and incontinence: the Canadian Urinary Bladder Survey. BJU Int. 2008 Jan;101(1):52–8.
Drangsholt S, Ruiz MJA, Peyronnet B, Rosenblum N, Nitti V, Brucker B. Diagnosis and management of nocturia in current clinical practice: who are nocturia patients, and how do we treat them? World J Urol. 2019 Jul;37(7):1389–94.
Akhavizadegan H, Locke JA, Stothers L, Kavanagh A. A comprehensive review of adult enuresis. Can Urol Assoc J = J l’Association des Urol du Canada. 2019 Aug;13(8):282–7.
Nguyen LN, Randhawa H, Nadeau G, Cox A, Hickling D, Campeau L, et al. Canadian Urological Association best practice report: Diagnosis and management of nocturia. Can Urol Assoc J = J l’Association des Urol du Canada. 2022 Jul;16(7):E336–49.
Portman DJ, Gass MLS. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and the North American Menopause Society. Menopause. 2014 Oct;21(10):1063–8.
Peyronnet B, Brucker BM, Michel MC. Lower Urinary Tract Symptoms: What’s New in Medical Treatment? Eur Urol Focus. 2018 Jan;4(1):17–24.
Leslie SW, Sajjad H, Singh S. Nocturia. In Treasure Island (FL); 2023.
Moon S, Kim YJ, Chung HS, Yu JM, Park II, Park SG, et al. The Relationship Between Nocturia and Mortality: Data From the National Health and Nutrition Examination Survey. Int Neurourol J. 2022 Jun;26(2):144–52.
Ku JH, Hong SK, Kim HH, Paick J-S, Lee SE, Oh S-J. Is questionnaire enough to assess number of nocturic episodes?: Prospective comparative study between data from questionnaire and frequency-volume charts. Urology [Internet]. 2004;64(5):966–9. Available from: https://www.sciencedirect.com/science/article/pii/S0090429504007459
Bliwise DL, Howard LE, Moreira DM, Andriole GL, Hopp ML, Freedland SJ. Nocturia and associated mortality: observational data from the REDUCE trial. Prostate Cancer Prostatic Dis. 2019 Mar;22(1):77–83.
Funada S, Tabara Y, Setoh K, Negoro H, Akamatsu S, Yoshino T, et al. Impact of Nocturia on Mortality: The Nagahama Study. J Urol. 2020 Nov;204(5):996–1002.
Endeshaw YW, Schwartz A V, Stone K, Caserotti P, Harris T, Smagula S, et al. Nocturia, Insomnia Symptoms and Mortality among Older Men: The Health, Aging and Body Composition Study. J Clin sleep Med JCSM Off Publ Am Acad Sleep Med. 2016 Jun;12(6):789–96.
Chow P-M, Chuang Y-C, Hsu KCP, Shen Y-C, Hsieh AW-J, Liu S-P. Impacts of nocturia on quality of life, mental health, work limitation, and health care seeking in China, Taiwan and South Korea (LUTS Asia): Results from a cross-sectional, population-based study. J Formos Med Assoc. 2022 Jan;121(1 Pt 2):285–93.
Bing MH, Moller LA, Jennum P, Mortensen S, Lose G. Nocturia and associated morbidity in a Danish population of men and women aged 60-80 years. BJU Int. 2008 Sep;102(7):805–8.
Fitzgerald MP, Litman HJ, Link CL, McKinlay JB. The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: results from the BACH survey. J Urol. 2007 Apr;177(4):1385–9.
Gourova LW, van de Beek C, Spigt MG, Nieman FHM, van Kerrebroeck PEVA. Predictive factors for nocturia in elderly men: a cross-sectional study in 21 general practices. BJU Int. 2006 Mar;97(3):528–32.
Hashim H, Blanker MH, Drake MJ, Djurhuus JC, Meijlink J, Morris V, et al. International Continence Society (ICS) report on the terminology for nocturia and nocturnal lower urinary tract function. Neurourol Urodyn. 2019 Feb;38(2):499–508.
Batista JE, Kölbl H, Herschorn S, Rechberger T, Cambronero J, Halaska M, et al. The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results of a noninferiority, randomized, phase IIIb trial. Ther Adv Urol. 2015 Aug;7(4):167–79.
Weiss JP, Herschorn S, Albei CD, van der Meulen EA. Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study. J Urol. 2013 Sep;190(3):965–72.
Pesonen JS, Cartwright R, Vernooij RWM, Aoki Y, Agarwal A, Mangera A, et al. The Impact of Nocturia on Mortality: A Systematic Review and Meta-Analysis. J Urol. 2020 Mar;203(3):486–95.
Obayashi K, Saeki K, Kurumatani N. Independent Associations Between Nocturia and Nighttime Blood Pressure/Dipping in Elderly Individuals: The HEIJO-KYO Cohort. J Am Geriatr Soc. 2015 Apr;63(4):733–8.
Kupelian V, Fitzgerald MP, Kaplan SA, Norgaard JP, Chiu GR, Rosen RC. Association of nocturia and mortality: results from the Third National Health and Nutrition Examination Survey. J Urol. 2011 Feb;185(2):571–7.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Journal of Advance Research in Medical & Health Science (ISSN: 2208-2425)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
